Table II.
microRNA | Target gene | Activity/significance | Reference |
---|---|---|---|
miR-1 | HDAC4, MEF2C |
|
[19, 32] |
miR-133a | SRF |
|
[20, 32, 34] |
miR-128a | Isl1, Sfrp5, Hcn4, Irx4 |
|
[21, 57, 58, 59] |
cluster of miR-17-92 | PTEN, CDK1 | Regulation of cardiomyocyte proliferation in embryonic, postnatal, and adult hearts | [23, 60, 61] |
miR-15 miR-16 |
C/EBPβ, IGF1 | Protection/downregulation of cardiac hypertrophy | [54] |
miR-208b | β-MHC, Sox6, Purβ, Sp3, HP1β |
|
[25] [37] |
miR-499 | Sox6, cyclin D1 | Inhibition of cell proliferation and promotion of cell apoptosis in P19CL6 cells and cardiomyocytes | [38] [39] |
miR-133b | PTBP1, TAGLN2 | Alleviates apoptosis and cardiac fibrosis, modulates collagen deposition | [53] |
miR-143/145 | HK2 | Addresses G6PD, PPP pathways and p62. Activation of these signaling pathways induces a reductive redox shift, resulting in cardiomyopathy | [55] |
miR-155 | NEDD4 | Cardioprotective against cardiomyocyte apoptosis; modulates myofibroblast density | [56] |
miR-218 | REST | Regulates cardiac differentiation of embryonic stem cells by regulating the Wnt/β-catenin signaling pathway and GATA4 | [63] |
miR-124 | STAT3 |
|
[64, 65] |
miR-21 | Ajuba/Isl1 | Differentiation of BMSCs into cardiomyocyte-like cells; contributes to formation and maintenance of cell-cell connections and supports cell division and migration | [66] |
miR-31 | CAMK2D, YWHAE | Promotes loss of dystrophin and nNOS in human | [67] |
miR-103/107 | PANKs, FADD | Modulates mitochondrial concentration; regulates systemic glucose metabolism; H2O2-induced necrosis | [68, 69] |
miR-200b | GATA-4 | Transcription factor; regulation of developmental processes of the heart, cardiac myocyte proliferation, differentiation and survival | [70] |
ANP – atrial natriuretic peptide, BMSCs – bone marrow-derived mesenchymal stem cells, CAMK2D – calcium/calmodulin dependent protein kinase II delta, CDK1 – cyclin dependent kinase 1, C/EBPβ – CCAAT enhancer binding protein beta, ESCs – embryonic stem cells, FADD – Fas-associated via death domain, G6PD – glucose-6-phosphate dehydrogenase, GATA4 – GATA binding protein 4, Hcn4 – hyperpolarization activated cyclic nucleotide gated potassium channel 4, HDAC4 – histone deacetylase 4, HK 2 – hexokinase 2, HP1β – heterochromatin protein 1β, IGF1 – insulin-like growth factor-1, Irx4 – iroquois homeobox 4, MEF2 – myocyte-specific enhancer factor 2, MHC – myosin heavy chains, mRNA – messenger ribonucleic acid, MyoD – myoblast determination protein 1, NEDD4 – neural precursor cell expressed developmentally down-regulated protein 4, nNOS – neuronal nitric oxide synthase, PANKs – pantothenate kinases, PPP – pentose phosphate pathway, PTBP1 – polypyrimidine tract-binding protein 1, PTEN – phosphatase and tensin homolog, Purβ – purine rich element binding protein B, REST – RE1 silencing transcription factor, Sfrp5 – secreted frizzled related protein 5, Sox6 – SRY-box transcription factor 6, Sp3 – specificity protein 3, SRF – serum response factor, STAT3 – signal transducer and activator of transcription 3, TAGLN2 – transgelin 2, TnT – troponin T, YWHAE – tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon, Wnt – wingless/integrated.